Singh Satya P, Foley John F, Zhang Hongwei H, Hurt Darrell E, Richards Jennifer L, Smith Craig S, Liao Fang, Farber Joshua M
Laboratory of Molecular Immunology (S.P.S., J.F.F., H.H.Z., J.L.R., C.S.S., F.L., J.M.F.) and Bioinformatics and Scientific IT Program, Office of Technology Information Systems, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland (D.E.H.); and Howard Hughes Medical Institute, National Institutes of Health Research Scholars Program, Bethesda, Maryland (C.S.S.).
Laboratory of Molecular Immunology (S.P.S., J.F.F., H.H.Z., J.L.R., C.S.S., F.L., J.M.F.) and Bioinformatics and Scientific IT Program, Office of Technology Information Systems, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland (D.E.H.); and Howard Hughes Medical Institute, National Institutes of Health Research Scholars Program, Bethesda, Maryland (C.S.S.)
Mol Pharmacol. 2015 Nov;88(5):894-910. doi: 10.1124/mol.115.099960. Epub 2015 Aug 27.
CXCR6, the receptor for CXCL16, is expressed on multiple cell types and can be a coreceptor for human immunodeficiency virus 1. Except for CXCR6, all human chemokine receptors contain the D(3.49)R(3.50)Y(3.51) sequence, and all but two contain A(3.53) at the cytoplasmic terminus of the third transmembrane helix (H3C), a region within class A G protein-coupled receptors that contacts G proteins. In CXCR6, H3C contains D(3.49)R(3.50)F(3.51)I(3.52)V(3.53) at positions 126-130. We investigated the importance and interdependence of the canonical D126 and the noncanonical F128 and V130 in CXCR6 by mutating D126 to Y, F128 to Y, and V130 to A singly and in combination. For comparison, we mutated the analogous positions D142, Y144, and A146 to Y, F, and V, respectively, in CCR6, a related receptor containing the canonical sequences. Mutants were analyzed in both human embryonic kidney 293T and Jurkat E6-1 cells. Our data show that for CXCR6 and/or CCR6, mutations in H3C can affect both receptor signaling and chemokine binding; noncanonical H3C sequences are functionally linked, with dual changes mitigating the effects of single mutations; mutations in H3C that compromise receptor activity show selective defects in the use of individual Gi/o proteins; and the effects of mutations in H3C on receptor function and selectivity in Gi/o protein use can be cell-type specific. Our findings indicate that the ability of CXCR6 to make promiscuous use of the available Gi/o proteins is exquisitely dependent on sequences within the H3C and suggest that the native sequence allows for preservation of this function across different cellular environments.
CXCR6是CXCL16的受体,在多种细胞类型上表达,并且可以作为人类免疫缺陷病毒1的共受体。除CXCR6外,所有人类趋化因子受体都含有D(3.49)R(3.50)Y(3.51)序列,并且除两个受体外,所有受体在第三个跨膜螺旋(H3C)的细胞质末端都含有A(3.53),A(3.53)是A类G蛋白偶联受体中与G蛋白接触的一个区域。在CXCR6中,H3C在第126 - 130位含有D(3.49)R(3.50)F(3.51)I(3.52)V(3.53)。我们通过将D126突变为Y、F128突变为Y以及V130突变为A,单独及组合突变来研究CXCR6中典型的D126以及非典型的F128和V130的重要性及相互依赖性。为作比较,我们在含有典型序列的相关受体CCR6中,将类似位置的D142、Y144和A146分别突变为Y、F和V。在人类胚胎肾293T细胞和Jurkat E6 - 1细胞中对突变体进行了分析。我们的数据表明,对于CXCR6和/或CCR6,H3C中的突变可影响受体信号传导和趋化因子结合;非典型的H3C序列在功能上相互关联,双重变化可减轻单突变的影响;损害受体活性的H3C突变在使用单个Gi/o蛋白时表现出选择性缺陷;并且H3C突变对受体功能和Gi/o蛋白使用选择性的影响可能具有细胞类型特异性。我们的研究结果表明,CXCR6对可用Gi/o蛋白的混杂使用能力高度依赖于H3C内的序列,并表明天然序列允许在不同细胞环境中保留此功能。